Big Pharma

The Cost Of Corporate Profit In US Health Care Reaches $2 Trillion

November 10, 2024 Pete Dolack, ZNetwork. Educate! Big Pharma, Health Care, Iowa, Medicare for all, Worker Rights and Jobs

As has long been the case, the U.S. health care system is by far the world’s most expensive while providing the worst results among the world’s advanced capitalist countries. And that expense continues to get larger and more unaffordable. Just how large is the cost of private profit in health care? Almost two trillion dollars! Unbelievable? It certainly seems so. But that is indeed how much more money the people of the United States spent on health care in 2022 than they would otherwise have spent if the U.S. had a single-payer system.

Mapped: How Big Industries Hope To Sway The UN Biodiversity Talks

October 30, 2024 Hazel Healy and Rachel Sherrington, DeSmog. Educate! Activism, Big Ag, Big Pharma, Biodiversity, Colombia, COP16, Environment, Finance and the Economy, Food and Agriculture, Pesticides, Social Justice, United Nations (UN)

Under thundery tropical skies, and amid ever more dire warnings on the precarious state of the world’s ecosystems, the United Nations Biodiversity Conference is unfolding in Colombia. This year’s summit, known as COP16, follows on from the last biodiversity conference held in Montréal in 2022, when negotiators struck an historic deal – the equivalent of the Paris Agreement on climate change – to “halt and reverse” nature loss. Now, government representatives from nearly 200 countries, along with scientists, Indigenous groups, and environmental activists, are gathered in the southern city of Cali to negotiate how to put this plan into action: protect earth’s habitats and the people who depend on them.

Diabetes Patients Are Starting To Beat Big Pharma’s Price Gouging

October 18, 2024 Fran Quigley, Waging Nonviolence. Organize! Big Pharma, Diabetes, Health Care, Insulin, Victory

T1International was born out of anger. Elizabeth Pfiester had lived with type 1 diabetes since she was four years old. The daughter of a Monticello, Illinois railroad worker and library clerk, Pfiester and her family together had to learn the daily regimen of insulin injections, finger pricks for blood testing, and constant fear of blood sugar spikes and crashes. Fortunately, her dad’s railroad job provided solid health coverage, which got even better when Pfiester enrolled in the London School of Economics, where she qualified for the U.K.’s National Health Service program.

The Supreme Court And The Sackler Bankruptcy Settlement

July 1, 2024 F. Douglas Stephenson, Counter Punch. Educate! Big Pharma, Opioid crisis, Purdue, Sackler Family, SCOTUS, Supreme Court

Allen Frances, M.D., distinguished former chair of psychiatry at Duke University school of medicine wrote in a Oct., 2017 New Yorker magazine expose, “Their name (Sackler/Purdue Pharma) has been pushed forward as the epitome of good works and of the fruits of the capitalist system. But, when it comes down to it, they’ve earned this fortune at the expense of millions of people who are addicted. It’s shocking how they have gotten away with it.” Long overdue, the Sacklers and Big Pharma are finally starting to pay for the opioid crisis. In a recent 5-4 decision, the U.S. Supreme Court rejected Purdue Pharma’s controversial bankruptcy settlement that protected the billionaire Sackler family from further liability for the opioid epidemic in the USA.

Public Pharma For Europe, A Game-Changer For Access To Medicines

February 11, 2024 People's Health Dispatch, People's Dispatch. Create! Big Pharma, Europe, Health Care, Patents, Public ownership

“It’s time to step up, promote health justice, and meet the real needs of people,” says Alan Silva from the European chapter of the People’s Health Movement (PHM), addressing the need for revolutionizing pharma policies in Europe. A long-time advocate for access to medicines, Silva understands how important it is for Europe to change the way it thinks about research and development, but also production and distribution of health technologies. If the region were able to de-link itself from the interests of transnational pharmaceutical companies, it would be a true game changer, he says. “We need public pharma in Europe so we can stop relying on health solutions driven by profit,” he says.

The Final Nail In Psychiatry’s Antidepressant Coffin

January 18, 2024 Bruce E. Levine, Counter Punch. Educate! Antidepressants, Big Pharma, Health Care, Medications, mental health, Psychiatry

Historically, there have always been some patients who report that any treatment for depression—including bloodletting—has worked for them, but science demands that for a treatment to be deemed truly effective, it must work better than a placebo or the passage of time without any treatment. This is especially important for antidepressant drugs—including Prozac, Zoloft, and other selective serotonin reuptake inhibitors (SSRIs), as well as Effexor, Cymbalta, and other serotonin and norepinephrine reuptake inhibitors (SNRIs)—because all of these drugs have uncontroversial troubling side effects.

Health Activists Reveal Big Pharma’s Covid-19 Vaccine Heist In South Africa

September 7, 2023 People's Health Dispatch. Educate! Big Pharma, COVID-19, Global South, Janssen, Pfizer, South Africa, Vaccine apartheid, Vaccines

In August this year, a coalition of civil society organizations in South Africa, which includes the Health Justice Initiative (HJI) and the Public Service Accountability Monitor (PSAM), achieved a remarkable breakthrough in the discussion surrounding COVID-19 vaccines. This milestone was reached after the Pretoria High Court issued an order instructing the Department of Health to disclose the contracts and proceedings of meetings pertaining to the procurement of COVID-19 vaccine doses from Pfizer, Janssen, the Serum Institute of India, and the public-private global health partnership Gavi.

This Is How We Challenge The Power Of Big Pharma

September 4, 2023 Margaret Flowers, Clearing the FOG. Podcast - Clearing The FOG Big Pharma, Capitalism, Drug Shortages, Health Care

People in the United States pay the highest prices for pharmaceuticals, and Big Pharma spends hundreds of millions of dollars every year for lobbying to keep it that way. The United States is also experiencing a growing shortage of medications from antibiotics to cancer treatments and more despite being a wealthy country. Clearing the FOG speaks with Dana Brown of the Democracy Collaborative to understand what is behind the high prices and shortages. She also describes solutions to these crises and how states across the country are taking action to directly confront the stranglehold the pharmaceutical industry has over our lives.

Big Pharma’s American Con

September 3, 2023 Andrew Perez, The Lever. Educate! Big Pharma, Capitalism, Health Care, Joe Biden

In response to this week’s launch of a new program letting Medicare negotiate lower prices for a handful of medicines, drugmakers are insisting the initiative will limit patients’ access to medicine and stifle the development of new cures. However, all 10 of the drugs up for negotiation are already being sold in other countries at fractions of what pharmaceutical companies are charging for them in the United States, according to a Lever review — and drugmakers are reporting huge revenues from those foreign sales. In some cases, Americans — whose tax money subsidizes the development of virtually all medicines approved for sale in the U.S. — are being charged 1,000 percent more than foreign patients for the same drugs.

Drug Patents Are Stifling Progress And Making Us Sicker

August 16, 2023 Mike Pappas, Left Voice. Educate! Big Pharma, Capitalism, Health Care, Patents

The healthcare system in the U.S. shows time and time again that under capitalism, profit maximization trumps individual and societal well-being. We saw a recent example from Gilead Sciences manipulating patent laws to extend the life of one of their drugs and delay the release of another, potentially safer option. Gilead’s efforts serve as just one example of how under capitalism patent laws are used to maximize profits at the expense of public well-being. In the world of HIV/AIDS treatment and prevention, many of the more recent treatments center on using a combination of different drugs that target different parts of HIV’s replication cycle.

Public Pharma Is The Best Solution To The Problem Of Drug Shortages

August 13, 2023 Dana Brown and Christopher Morten, STAT. Create! Big Pharma, Health Care, Medications, Public ownership

Drug shortages in the United States are at a record high. At least 14 essential generic cancer drugs are currently in shortage, forcing patients and doctors to make difficult decisions to delay or ration first-line treatments, or accept second-best treatments. ADHD treatments, antibiotics, children’s acetaminophen, and many other critical medicines are also in short supply. But most of the solutions being discussed are just Band-Aids on a broken system. They would do nothing to transform the incentives that routinely produce shortages and other market failures. What we really need — for the health of our economy and society — is a robust public option in pharmaceuticals that produces and distributes essential medicines, such as cancer treatments.

Millions Of People In The US Ration Medicine

June 18, 2023 Natalia Marques, People's Dispatch. Educate! Big Pharma, Capitalism, Finance and the Economy, Health Care

A new Centers for Disease Control and Prevention (CDC) report published this month reveals that approximately 9.2 million people in the US try to save money by rationing their medication. Most adults between the ages of 18 and 64 take at least one prescription medication, but 8% of them—9.2 million people—ration medicine by skipping doses, taking less than instructed, or delaying a refill. Meanwhile, pharmaceutical giants like Merck are fighting tooth and nail against President Biden’s limited checks on astronomical medication prices. Giving the government power to negotiate medicine prices with companies is “tantamount to extortion,” Merck argues in a recent lawsuit.

A Big Miss On Drug Prices

March 27, 2023 David Dayen, The American Prospect. Educate! Big Pharma, Drug Prices, Health Care, Joe Biden

The Biden administration has seen firsthand in the past few weeks the benefits of using statutory power to bring down prescription drug costs. With Novo Nordisk and Sanofi following the lead of Eli Lilly and announcing their intent to slash the list price of their insulin medications by 65 percent or more, practically all diabetes patients will see relief, mostly thanks to a change in Medicaid rebates stuck into the American Rescue Plan. It upended the usual laissez-faire attitude about prescription price-gouging, and showed that the government, as a major medication buyer, can intervene to lower costs.

NHS Price Problem Is Big Pharma, Not Striking Nurses

December 24, 2022 Tarun Gidwani, Consortium News. Educate! Big Pharma, Health Care, NHS, Strikes, Worker Rights and Jobs

Imagine a disability almost disappearing if you flew out of the Global South. I have severe haemophilia, a genetic condition that interferes with the body’s ability to clot after bleeding. When left untreated, anything — even a bruise or merely sitting down — can trigger a bleed, internally or externally. Anti-clotting injections can stop this. However, outside the advanced West, these injections are sold at exorbitantly high prices. When I was a child in India, my parents couldn’t afford such treatment, so they’d bury my bleeding joints under piles of ice to freeze them. Almost all the bleeds I experienced in India were left untreated, resulting in permanent damage to my joints and internal organs. In the U.K., the NHS home-delivers me these injections twice a month. This global medical apartheid is created and perpetuated by pharmaceutical monopolies.

Brazil: Pharma Companies Attempt To Overturn Supreme Court’s Historic Decision On Patents

December 19, 2022 Felipe Carvalho Borges Da Fonseca, People's Dispatch. Resist! Big Pharma, Brazil, Health Care, Supreme Court

The barriers that certain intellectual property rules can generate – preventing the fair distribution of vaccines and medicines – are a recurring theme in debates on global health. Traumatic experiences such as the HIV/AIDS treatment access crisis in the 90s, the global rationing of hepatitis C treatment in 2014, and the unfair distribution of COVID-19 vaccines are concrete examples of the right to health being systematically violated when monopolies over medical technologies are established and exercised arbitrarily. It is urgent to recognize, expose and confront the abuses that are committed in the patent system that result in death and suffering for millions of people. In Brazil, we are currently experiencing a situation of triple abuse, which threatens the populations’ access to dozens of essential medicines.

«1 2 3 4 5 6 »

Daily movement news and resources